SARTAX HCT 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Kauptu það núna

Opinber matsskýrsla Opinber matsskýrsla (PAR)
28-11-2017

Virkt innihaldsefni:

hydrochlorothiazide, Quantity: 12.5 mg; irbesartan, Quantity: 300 mg

Fáanlegur frá:

Medis Pharma Pty Ltd

INN (Alþjóðlegt nafn):

Hydrochlorothiazide,Irbesartan

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000

Stjórnsýsluleið:

Oral

Einingar í pakka:

30s

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

For the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.

Vörulýsing:

Visual Identification: Peach coloured, oval shaped, biconvex, film coated tablet, debossed with "L184" on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Registered

Leyfisdagur:

2012-11-13